| Gene symbol | CD99 | Synonyms | HBA71, MIC2, MIC2X, MIC2Y, MSK5X | Type of gene | protein-coding |
| Chromosome | X|Y | Map location | X;Y | dbXrefs | |
| Description | CD99 molecule (Xg blood group) | ||||
| GTO ID | GTC0932 |
| Trial ID | ChiCTR2100046764 |
| Disease | Hematologic Cancer |
| Altered gene | CD99 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD99 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | A single-center, open-label and single-arm clinical research of chimeric antigen receptor T cells in the treatment of relapsed and refractory CD99-positive hemalogical maligancies |
| Year | 2021 |
| Country | China |
| Company sponsor | The First Affiliated Hospital of Nanchang University |
| Cohort 1 | |||||||
|
|||||||